Annual Jefferson ILD Symposium on October 10, 2025 in Philadelphia, United States

The 3rd Annual Jefferson Interstitial Lung Disease Conference is designed to provide healthcare professionals with a comprehensive overview of the latest advances in the diagnosis, management, and treatment of ILD. This educational activity will feature expert-led lectures, interactive case discussions, and evidence-based updates on current and emerging therapies.

Participants will gain insights into the evolving understanding of ILD pathophysiology, including idiopathic pulmonary fibrosis (IPF), connective tissue disease-associated ILD, hypersensitivity pneumonitis, and other fibrosing lung diseases.

Special emphasis will be placed on diagnostic challenges, multidisciplinary care models, and the role of high-resolution imaging, serologies, and lung biopsy in clinical decision-making. Attendees will also explore updates on pharmacologic therapies, including antifibrotic agents and immunomodulators.

This conference aims to foster knowledge exchange, promote best practices, and support the delivery of high-quality, patient-centered ILD care across various practice settings.